×
For best experience we recommend to activate Javascript in your browser.
HLA-DRA antibody (AA 27-216) (FITC)
This Rabbit Polyclonal antibody specifically detects HLA-DRA in FACS. It exhibits reactivity toward Human.
Quick Overview for HLA-DRA antibody (AA 27-216) (FITC) (ABIN7617464)
Target
See all HLA-DRA Antibodies
HLA-DRA
(HLA Class II DR alpha (HLA-DRA))
Reactivity
All reactivities for HLA-DRA antibodies
Human
Host
All hosts for HLA-DRA antibodies
Rabbit
Clonality
All clonalities for HLA-DRA antibodies
Polyclonal
Conjugate
All conjugates for HLA-DRA antibodies
This HLA-DRA antibody is conjugated to FITC
Application
All applications for HLA-DRA antibodies
Flow Cytometry (FACS)
Product Details anti-HLA-DRA Antibody (FITC)
(hide)
Binding Specificity
All epitopes for HLA-DRA antibodies
AA 27-216
Purpose
FITC-Linked Anti-HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody
Sequence
Lys27~Glu216
Characteristics
The FITC-Linked Anti-HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody (Species: Human) has been validated for the following applications: Flow cytometry.
Purification
Affinity Chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for HLA-DRA
(hide)
Target
HLA-DRA
(HLA Class II DR alpha (HLA-DRA))
Alternative Name
HLA-DRA
Gene ID
3122
UniProt
P01903
Pathways
TCR Signaling , CXCR4-mediated Signaling Events , Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Recently viewed
(hide)
Chat with us , powered by LiveChat